D Kotasek

Summary

Country: Australia

Publications

  1. ncbi Darbepoetin alfa administered every 3 weeks alleviates anaemia in patients with solid tumours receiving chemotherapy; results of a double-blind, placebo-controlled, randomised study
    D Kotasek
    Ashford Cancer Centre, 15 Alexander Avenue, Ashford SA 5035, Australia
    Eur J Cancer 39:2026-34. 2003

Detail Information

Publications1

  1. ncbi Darbepoetin alfa administered every 3 weeks alleviates anaemia in patients with solid tumours receiving chemotherapy; results of a double-blind, placebo-controlled, randomised study
    D Kotasek
    Ashford Cancer Centre, 15 Alexander Avenue, Ashford SA 5035, Australia
    Eur J Cancer 39:2026-34. 2003
    ..Administration of darbepoetin alfa Q3W has a tolerable safety profile and effectively ameliorates anaemia due to chemotherapy...